Vimarsana
Biggest News Aggregation in the World

Page 20 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

Astellas Pharma (OTCMKTS:ALPMY) Stock Crosses Below Fifty Day Moving Average of $11.66 - Vimarsana News

Astellas Pharma (OTCMKTS:ALPMY) Stock Crosses Below Fifty Day Moving Average of $11.66

Shares of Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $11.66 and traded as low as $10.77. Astellas Pharma shares last traded at $10.82, with a volume of 182,653 shares changing hands. Astellas Pharma Price Performance […]

ESSA Pharma (NASDAQ:EPIX) Issues Earnings Results - Vimarsana News

ESSA Pharma (NASDAQ:EPIX) Issues Earnings Results

ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) announced its quarterly earnings results on Tuesday. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.03, MarketWatch Earnings reports. ESSA Pharma Stock Performance EPIX opened at $9.91 on Thursday. The firm’s 50-day simple moving average is $7.76 […]

ESSA Pharma (NASDAQ:EPIX) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS - Vimarsana News

ESSA Pharma (NASDAQ:EPIX) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS

ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) announced its earnings results on Tuesday. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.17) by $0.03, MarketWatch Earnings reports. ESSA Pharma Stock Up 2.7 % Shares of EPIX stock opened at $9.91 on Thursday. ESSA Pharma has a […]

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP) - Vimarsana News

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

Glancy Prongay & Murray LLP announces its investigation of MEI Pharma, Inc. concerning the Company and its directors’ and officers’ possible violations of state laws. If you own MEI Pharma...

Investment Analysts' Weekly Ratings Changes for MEI Pharma (MEIP) - Vimarsana News

Investment Analysts' Weekly Ratings Changes for MEI Pharma (MEIP)

Several analysts have recently updated their ratings and price targets for MEI Pharma (NASDAQ: MEIP): 2/14/2024 – MEI Pharma had its price target lowered by analysts at Stifel Nicolaus from $8.00 to $7.00. They now have a “hold” rating on the stock. 2/13/2024 – MEI Pharma was downgraded by analysts at StockNews.com from a “buy” […]